InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NSPR on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
42,079,879
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,730,210
Holdings value
$54,778,990
% of all portfolios
0%
Number of holders
40
Number of buys
24
Number of sells
-8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MARSHALL WACE, LLP 9.99% $67,729,915 28,103,699 MARSHALL WACE, LLP 30 Sep 2025
Rosalind Advisors, Inc. 9.9% +5.6% $25,929,565 10,987,104 0% Rosalind Advisors, Inc. 01 Aug 2025
Nantahala Capital Management, LLC 9.99% 0% $10,256,307 +$2,934,884 4,255,729 +40% Nantahala Capital Management, LLC 30 Sep 2025
Lawless Michael A 8.6% $8,711,502 3,614,731 Michael A. Lawless 26 Jun 2025
Aberdeen Group plc 5.95% $5,979,492 2,481,117 Aberdeen Group plc 01 Oct 2025
Parkman Healthcare Partners LLC 5.8% $5,881,926 2,440,633 Parkman Healthcare Partners LLC 30 Sep 2025
Nantahala Capital Partners Limited Partnership 5.68% $5,827,419 2,418,016 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
Velan Capital Investment Management LP 5.1% $5,059,127 2,143,698 Velan Capital Master Fund LP 30 Jul 2025
ORBIMED ADVISORS LLC 4.1% -44% $5,141,506 2,133,405 0% OrbiMed Advisors LLC 30 Sep 2025
Shore Craig 3.5% $3,577,657 1,484,505 Craig Shore 26 Jun 2025

Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,730,210 $54,778,990 +$20,913,736 $2.41 40
2025 Q2 14,061,920 $31,922,818 +$2,512,314 $2.27 36
2025 Q1 12,917,013 $34,746,467 +$554,615 $2.69 34
2024 Q4 12,710,904 $33,407,511 +$811,860 $2.63 29
2024 Q3 12,402,374 $33,215,449 +$1,209,473 $2.68 27
2024 Q2 11,951,922 $29,859,952 +$4,430,429 $2.5 23
2024 Q1 10,178,288 $23,962,111 -$399,400 $2.37 25
2023 Q4 10,339,444 $29,052,785 +$1,719,804 $2.81 27
2023 Q3 8,762,240 $28,676,783 +$2,327,230 $3.27 25
2023 Q2 8,054,251 $20,221,241 +$20,007,582 $2.51 22
2023 Q1 88,752 $103,127 -$54,760 $1.12 12
2022 Q4 155,809 $137,173 +$21,576 $0.8595 14
2022 Q3 112,334 $168,630 -$78,516 $1.5 11
2022 Q2 129,060 $256,202 -$10,358 $1.99 10
2022 Q1 140,275 $455,524 -$96,895 $3.21 13
2021 Q4 172,505 $527,325 -$27,335 $3.02 15
2021 Q3 170,103 $703,514 -$1,360,154 $4.1 12
2021 Q2 450,832 $2,277,560 +$2,277,560 $5.05 14